On #WorldObesityDay, we highlight the breakthroughs in treatment of obesity as well as the concerning trend of low adherence and persistence rates to GLP-1 therapies. Despite proven effectiveness, many people living with obesity struggle to maintain GLP-1 treatment regimens, creating a gap between clinical efficacy and real-world outcomes. Our new Evidence for Change article provides a summary of a recent real-world study on GLP-1 therapy adherence and persistence. Read the article here: https://bit.ly/3QJoI7F
Atlantis Health
制药业
Summit，New Jersey 7,390 位关注者
Transforming Patient Engagement with the latest Behavioral Science and Technology
关于我们
Atlantis Health designs and delivers evidence-based health behavior change and patient engagement solutions for pharmaceutical, biotech and healthcare organizations around the world. We empower people to manage their treatment and health journey, improving outcomes and impact. Our solutions leverage our core capabilities of health psychology-informed behavioral strategy, co-designed content and digital experiences and data-driven personalization technologies. Our purpose: To help people Change for Good by empowering them to achieve health goals that will positively impact their lives and the lives of those around them. Since 1996, we have expanded to become a global group of companies with offices in the United States, United Kingdom, Germany, Australia and New Zealand. Worldwide, we help our clients to achieve their patient engagement and behavior change objectives, provide better patient experiences, and gain valuable real-world data and insights. Our solutions have helped people across more than 30 countries, and over 100 different health conditions ranging from ultra-rare and orphan diseases to common conditions, including cancer, type 2 diabetes and asthma.
- 网站
-
https://www.atlantishealth.com/
Atlantis Health的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Summit，New Jersey
- 类型
- 私人持股
- 创立
- 1996
- 领域
- Health psychology、Patient self management、Digital Health、Pharmaceutical Industry、Data-driven programs、Personalization technologies、Patient engagement、Medication Adherence solutions、Co-design、Multichannel support solutions、Patient support programs、Health behavior、Behavior Change、Behavioral Science、Clinical trial support、Health coaching、Contact Center Services、Life Sciences Industry和Treatment adherence
地点
Atlantis Health员工
动态
-
300 million people worldwide live with a rare disease, and for many, the journey is isolating and complex. This #RareDiseaseDay, we’re sharing patient perspectives that highlight why comprehensive #patientengagement solutions are so highly valued—helping patients navigate the challenges of living with a rare condition. Learn more about one of our solutions designed with rare disease patients to improve access and provide personalized support: https://bit.ly/43dWNV0
-
Cancer is more than just a diagnosis, it is a deeply personal journey. Effective support for someone living with cancer requires an understanding of their unique needs and challenges. #UnitedByUnique This #WorldCancerDay, we want to highlight our meaningful work alongside life sciences and pharma partners to co-design, develop, and implement personalized #behaviorchange solutions that deliver positive impact through #patientengagement and empowerment. Read a cancer-focused case study here: https://bit.ly/40FVTxt
-
-
What does the future of #medicationadherence involve? Our first Evidence for Change edition of the year features a publication discussing the top 10 targets for improving medication nonadherence in the years to come, with the key lying in the fields of #behavioralscience and #healthpsychology. Read the article here: https://bit.ly/4gkUhii #patientengagement
-
-
We're looking for a Senior Sales Engineer with a Digital Health focus to join us as a core technical sales lead for our US operation, and also supporting the UK and Germany teams. This role will understand, shape, and articulate customer technical requirements and sell innovative solutions using Atlantis Health platforms. Full details and link to apply are available here: https://lnkd.in/eRAdps7a
-
Congratulations to all our MyPal H2020 research partners on the study results presented at the 2024 American Society of Hematology meeting. The project demonstrated improvements in quality of life for blood cancer patients, leveraging digital health technology and patient-reported outcomes to enhance the delivery of palliative care.
?? Post-Event Update: MyPal H2020 at #ASH24! ?? The MyPal H2020 study was successfully presented at the 66th Annual American Society of Hematology Meeting in San Diego! ?? ?? You can see the abstract here: ?? https://lnkd.in/d_RGGVV8 ?? Dr. Thomas Chatzikonstantinou from the INAB - Institute of Applied Biosciences represented the team brilliantly, presenting the poster titled: "Improving Quality of Life on Electronic Patient-Reported Outcomes (ePROs) in patients with CLL and MDS: The #MyPal Study", and explained our findings to the participants in the poster area—showcasing the impact of our research. ?? The study highlighted innovative ways to improve the quality of life for patients with #Chronic #Lymphocytic #Leukemia (#CLL) and #Myelodysplastic #Syndromes (#MDS) via ePRO-enabled technologies. We thank the participants for the meaningful discussions and their attention to the potential of digital health interventions in advancing palliative care. ?? A heartfelt thank you to the European Union's Horizon 2020 program, our incredible partners, and every team member whose dedication made this presentation a success. This milestone reminds us of the importance of collaborative efforts in driving healthcare innovation. Learn more about the MyPal project here: ?? https://lnkd.in/dDFw74xV Thank you to all partner organizations for this incredible journey! ?? Together, we’re paving the way for better care solutions for patients, caregivers, and healthcare providers. ???? Centre for Research & Technology Hellas (CERTH) | INAB - Institute of Applied Biosciences | Foundation for Research and Technology - Hellas (FORTH) | ICS-FORTH | Fraunhofer-Gesellschaft | Lancaster University | Masaryk University | Karolinska Institutet | Libera Università Vita-Salute San Raffaele | Hannover Medical School | University Hospital Brno | Promotion Software GmbH | Atlantis Health | European Association for Palliative Care | International Children's Palliative Care Network | University of West Attica #PalliativeCare #eHealth #mHealth #MyPalProject #ASH24 #InnovationInCare #QualityOfLife #ePRO #PRO
-
-
As we celebrate another year of empowering individuals in their health journeys, we're grateful for the support of our community of patients, healthcare professionals, partners, and colleagues. Our mission remains focused on providing meaningful solutions for people living with chronic health conditions through #behaviorchange strategies and solutions. Change for Good is more than a slogan—it's our commitment to helping people take control of their health, one positive step at a time. Thank you to all for your trust and dedication. Wishing you a healthy and hopeful holiday season. #patientengagement?#patientsupportprograms
-
-
Our latest Evidence for Change article looks at the role of co-design in digital health intervention development. Bringing key stakeholders into the process significantly enhances intervention relevance and effectiveness. You can read our latest article here: https://bit.ly/4fI8y8V #patientengagement #behaviorchange #patientsupportprograms
-
-
Atlantis Health UK are delighted to have been selected as a finalist at this year’s PMEA awards in the category of Excellence in Engaging and Educating Patients! #PMEA2024
-
-
Climate action grows more important by the day. Small businesses - making up 90% of companies worldwide - play a huge role in tackling the climate crisis. We’re proud to be a member of the SME Climate Hub community with official recognition of our business’ commitment to reducing our environmental impact.?? Read more about the SME Climate Commitment and view our latest report here: https://lnkd.in/gwrArpkJ
-